Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jupiter Neurosciences, Inc. - Common Stock (NQ:JUNS)

0.2121 -0.0679 (-24.25%)
Streaming Delayed Price Updated: 10:26 AM EDT, Jun 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,775,648
Open 0.2073
Bid (Size) 0.2120 (100)
Ask (Size) 0.2139 (900)
Prev. Close 0.2800
Today's Range 0.2073 - 0.2200
52wk Range 0.1721 - 3.330
Shares Outstanding 34,426,355
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Monday's pre-market session. ↗
Via Chartmill
Friday's after hours session: top gainers and losers ↗
Via Chartmill

Performance

YTD
-79.0%
-79.0%
1 Month
-17.1%
-17.1%
3 Month
-34.7%
-34.7%
6 Month
-80.9%
-80.9%
1 Year
-79.2%
-79.2%

More News

Read More
MissionIRNewsBreaks – Jupiter Neurosciences Inc. (NASDAQ: JUNS) Closes $2 Million Registered Direct Offering
Via Investor Brand Network
News headline image
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering
Via ACCESS Newswire
What's going on in today's after hours session ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Most active stocks in Wednesday's session ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
Jupiter Neurosciences Investor News: Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
From Rosen Law Firm
Via Business Wire
News headline image
Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Jupiter Neurosciences Selected as B2i Digital Featured Company
Via NewMediaWire
News headline image
Jupiter Neurosciences Selected as B2i Digital Featured Company
Via TheNewswire.com
Unusual volume stocks in Thursday's session ↗
Via Chartmill
News headline image
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
Via NewMediaWire
News headline image
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
Via TheNewswire.com
News headline image
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
Via NewMediaWire
News headline image
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
Via TheNewswire.com
News headline image
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
Via TheNewswire.com
News headline image
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
Via NewMediaWire
News headline image
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
Via NewMediaWire
News headline image
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
Via TheNewswire.com

Frequently Asked Questions

Is Jupiter Neurosciences, Inc. - Common Stock publicly traded?
Yes, Jupiter Neurosciences, Inc. - Common Stock is publicly traded.
What exchange does Jupiter Neurosciences, Inc. - Common Stock trade on?
Jupiter Neurosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jupiter Neurosciences, Inc. - Common Stock?
The ticker symbol for Jupiter Neurosciences, Inc. - Common Stock is JUNS on the Nasdaq Stock Market
What is the current price of Jupiter Neurosciences, Inc. - Common Stock?
The current price of Jupiter Neurosciences, Inc. - Common Stock is 0.2121
When was Jupiter Neurosciences, Inc. - Common Stock last traded?
The last trade of Jupiter Neurosciences, Inc. - Common Stock was at 06/29/26 10:26 AM ET
What is the market capitalization of Jupiter Neurosciences, Inc. - Common Stock?
The market capitalization of Jupiter Neurosciences, Inc. - Common Stock is 7.30M
How many shares of Jupiter Neurosciences, Inc. - Common Stock are outstanding?
Jupiter Neurosciences, Inc. - Common Stock has 7M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.